{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:33:29Z","timestamp":1762850009950,"version":"build-2065373602"},"reference-count":32,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2025.2063","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T07:44:50Z","timestamp":1759218290000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Short\u2011term cognitive effects of anticholinergics in patients with neurogenic lower urinary tract dysfunction: A systematic review and meta\u2011analysis"],"prefix":"10.3892","volume":"23","author":[{"given":"Hui","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, First Affiliated Hospital of Huzhou University, Huzhou First People's Hospital, Huzhou, Zhejiang 313099, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, First Affiliated Hospital of Huzhou University, Huzhou First People's Hospital, Huzhou, Zhejiang 313099, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"50","key":"key20251111103042_b1-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1038\/s41394-021-00413-6","article-title":"The treatment of neurogenic lower urinary tract dysfunction in persons with spinal cord injury: An open label, pilot study of anticholinergic agent vs mirabegron to evaluate cognitive impact and efficacy","volume":"7","author":"Trbovich","year":"2021","journal-title":"Spinal Cord Ser Cases"},{"issue":"380","key":"key20251111103042_b2-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-019-1401-y","article-title":"Cumulative use of therapeutic bladder anticholinergics and the risk of dementia in patients with lower urinary tract symptoms: A nationwide 12-year cohort study","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Geriatr"},{"key":"key20251111103042_b3-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3978\/j.issn.2223-4683.2015.12.07","article-title":"Medical management of neurogenic bladder with oral therapy","volume":"5","author":"Cameron","year":"2016","journal-title":"Transl Androl Urol"},{"key":"key20251111103042_b4-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10286-013-0200-3","article-title":"Imidafenacin on bladder and cognitive function in neurologic OAB patients","volume":"23","author":"Sakakibara","year":"2013","journal-title":"Clin Auton Res"},{"issue":"k1315","key":"key20251111103042_b5-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1315","article-title":"Anticholinergic drugs and risk of dementia: Case-control study","volume":"361","author":"Richardson","year":"2018","journal-title":"BMJ"},{"key":"key20251111103042_b6-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","article-title":"Anticholinergic drug exposure and the risk of dementia: A nested case-control study","volume":"179","author":"Coupland","year":"2019","journal-title":"JAMA Intern Med"},{"key":"key20251111103042_b7-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2017.11.028","article-title":"Anti-cholinergic medications for bladder dysfunction worsen cognition in persons with multiple sclerosis","volume":"385","author":"Morrow","year":"2018","journal-title":"J Neurol Sci"},{"key":"key20251111103042_b8-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"227","DOI":"10.31887\/DCNS.2019.21.3\/pharvey","article-title":"Domains of cognition and their assessment","volume":"21","author":"Harvey","year":"2019","journal-title":"Dialogues Clin Neurosci"},{"issue":"56285","key":"key20251111103042_b9-BR-23-6-02063","article-title":"Cognitive function tests: Application of MMSE and MoCA in various clinical settings-a brief overview","volume":"34","author":"Oleksy","year":"2024","journal-title":"Qual Sport"},{"key":"key20251111103042_b10-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","article-title":"Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis","volume":"23","author":"Benedict","year":"2017","journal-title":"Mult Scler"},{"issue":"n71","key":"key20251111103042_b11-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"35","key":"key20251111103042_b12-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-015-0024-z","article-title":"The heterogeneity statistic I(2) can be biased in small meta-analyses","volume":"15","author":"von Hippel","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"key20251111103042_b13-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jclinepi.2022.10.003","article-title":"In a meta-analysis, the I-squared statistic does not tell us how much the effect size varies","volume":"152","author":"Borenstein","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"key20251111103042_b14-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/sc.2017.94","article-title":"The effects of antimuscarinic treatment on the cognition of spinal cord injured individuals with neurogenic lower urinary tract dysfunction: A prospective controlled before-and-after study","volume":"56","author":"Krebs","year":"2018","journal-title":"Spinal Cord"},{"key":"key20251111103042_b15-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1177\/21925682221110527","article-title":"Fixed-effect vs random-effects models for meta-analysis: 3 Points to consider","volume":"12","author":"Dettori","year":"2022","journal-title":"Global Spine J"},{"key":"key20251111103042_b16-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1515\/revneuro-2019-0089","article-title":"Amyloid-\u03b2, tau, and the cholinergic system in Alzheimer's disease: Seeking direction in a tangle of clues","volume":"31","author":"Majdi","year":"2020","journal-title":"Rev Neurosci"},{"issue":"e20220053","key":"key20251111103042_b17-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1590\/1980-5764-DN-2022-0053","article-title":"Cognitive effects of individual anticholinergic drugs: A systematic review and meta-analysis","volume":"17","author":"Naseri","year":"2023","journal-title":"Dement Neuropsychol"},{"key":"key20251111103042_b18-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/2168479015570332","article-title":"Sample size and the precision of the confidence interval in meta-analyses","volume":"49","author":"Liu","year":"2015","journal-title":"Ther Innov Regul Sci"},{"key":"key20251111103042_b19-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ajodo.2019.12.011","article-title":"Prediction interval in random-effects meta-analysis","volume":"157","author":"Spineli","year":"2020","journal-title":"Am J Orthod Dentofacial Orthop"},{"issue":"102172","key":"key20251111103042_b20-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102172","article-title":"The cambridge neuropsychological test automated battery (CANTAB) versus the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) for the assessment of cognitive function in patients with multiple sclerosis","volume":"43","author":"Talebi","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"102478","key":"key20251111103042_b21-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102478","article-title":"Pharmacotherapy in multiple sclerosis-induced cognitive impairment: A systematic review and meta-analysis","volume":"46","author":"Motavalli","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"key20251111103042_b22-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2125.2011.03961.x","article-title":"A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder","volume":"72","author":"Callegari","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"key20251111103042_b23-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1111\/j.1532-5415.2008.02009.x","article-title":"Cumulative anticholinergic exposure is associated with poor memory and executive function in older men","volume":"56","author":"Han","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"key20251111103042_b24-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000325171","article-title":"Effects of anticholinergic drugs on cognitive function in older Australians: Results from the AIBL study","volume":"31","author":"Sittironnarit","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"779607","key":"key20251111103042_b25-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.779607","article-title":"Anticholinergic burden and cognitive performance in patients with schizophrenia: A systematic literature review","volume":"12","author":"Georgiou","year":"2021","journal-title":"Front Psychiatry"},{"issue":"e00775","key":"key20251111103042_b26-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.775","article-title":"The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs","volume":"9","author":"Trenaman","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"key20251111103042_b27-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1055\/s-0043-1770093","article-title":"Mirabegron and anticholinergics in the treatment of overactive bladder syndrome: A meta-analysis","volume":"45","author":"Sartori","year":"2023","journal-title":"Rev Bras Ginecol Obstet"},{"key":"key20251111103042_b28-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00345-016-1908-1","article-title":"Combination treatment with mirabegron and solifenacin in patients with overactive bladder: Exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, phase II study (SYMPHONY)","volume":"35","author":"Abrams","year":"2017","journal-title":"World J Urol"},{"issue":"70","key":"key20251111103042_b29-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-70","article-title":"Investigation of publication bias in meta-analyses of diagnostic test accuracy: A meta-epidemiological study","volume":"14","author":"van Enst","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"1551","key":"key20251111103042_b30-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-021-01025-2","article-title":"Caution is advised when interpreting subgroup analyses","volume":"46","author":"Munkholm","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"e030205","key":"key20251111103042_b31-BR-23-6-02063","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030205","article-title":"Anticholinergic burden and fractures: A protocol for a methodological systematic review and meta-analysis","volume":"9","author":"Reinold","year":"2019","journal-title":"BMJ Open"},{"key":"key20251111103042_b32-BR-23-6-02063","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/ageing\/afaa090","article-title":"Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: A meta-analysis","volume":"49","author":"Pieper","year":"2020","journal-title":"Age Ageing"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:30:49Z","timestamp":1762849849000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2025.2063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,9,30]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2025.2063","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"type":"print","value":"2049-9434"},{"type":"electronic","value":"2049-9442"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}